Growth Hormone Control of Hepatic Lipid Metabolism

In humans, low levels of growth hormone (GH) and its mediator, IGF-1, associate with hepatic lipid accumulation. In mice, congenital liver-specific ablation of the GH receptor (GHR) results in reductions in circulating IGF-1 and hepatic steatosis, associated with systemic insulin resistance. Due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhongbo, Cordoba-Chacon, Jose, Kineman, Rhonda D., Cronstein, Bruce N., Muzumdar, Radhika, Gong, Zhenwei, Werner, Haim, Yakar, Shoshana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2016
Materias:
Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127251/
https://www.ncbi.nlm.nih.gov/pubmed/27679560
http://dx.doi.org/10.2337/db16-0649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127251/
https://www.ncbi.nlm.nih.gov/pubmed/27679560
http://dx.doi.org/10.2337/db16-0649

Ejemplares similares